Reversible clopidogrel resistance due to right ventricular myocardial infarction: Risk factor of recurrent stent thrombosis?

Clinical Research in Cardiology

Volumn 97, Issue 11, 2008, Pages 797-800

  Ibrahim, K ^a   Hass, N ^a   Kolschmann, S ^a   Strasser, R H ^a   Braun Dullaeus, R C ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Clopidogrel resistance; Right ventricular myocardial infarction; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY STENT; COUNTERPULSATION; DRUG RESISTANCE; ELECTROCARDIOGRAPHY; HEART REINFARCTION; HEART RIGHT VENTRICLE; HUMAN; LOADING DRUG DOSE; MALE; RISK FACTOR; ST SEGMENT ELEVATION; STENT THROMBOSIS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; ENOXAPARIN; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK FACTORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME; TYROSINE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 58549103091     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0679-0     Document Type: Article

References (9)

1. DJ Angiolillo 2007 Variability in individual responsiveness to clopidogrel J Am Coll Cardiol 49 1505 1516
2. DJ Angiolillo A Fernandez-Ortiz E Bernardo 2004 Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol 16 169 174
3. Angiolillo, Fernandez-Ortiz, Bernardo, et al. (2005) Platelet function profiles in patients with Type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54:2430-2435
4. Ellis et al. (2007) Incidence, timing and correlates of stentthombosis with the polymeric paclitaxel drug eluting stent. J Am Coll Cardiol 49:1043-1051
5. Fontana D (2003) ADP induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108:989-995
6. SC Smith 2006 ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article J Am Coll Cardiol 47 216 235
7. D Soffer I Moussa KJ Harjai 2003 Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina? Catheter Cardiovasc Interv 59 21 25
8. Spaulding et al. (2006) Sirolimus-eluting versus uncoated stents in acute myocaridal infarction. N Engl J Med 355:1093-1104
9. Spertus et al. (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Results from the PREMIER registry. Circulation 113:2803